Original Source(s)
Related Content
FDA Expands Afrezza to Pediatric Diabetes
The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.
May 29, 2026
-
3 min
Antibiotic Falls Short in Disc-Related Back Pain
A randomized trial found no greater pain reduction vs placebo, but questions remain about patients with type 1 Modic changes.
May 28, 2026
-
5 min